152 related articles for article (PubMed ID: 32094137)
1. Activity of Plazomicin Tested against
Castanheira M; Sader HS; Mendes RE; Jones RN
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094137
[TBL] [Abstract][Full Text] [Related]
2. Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms.
Castanheira M; Deshpande LM; Woosley LN; Serio AW; Krause KM; Flamm RK
J Antimicrob Chemother; 2018 Dec; 73(12):3346-3354. PubMed ID: 30219857
[TBL] [Abstract][Full Text] [Related]
3.
Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
Clark JA; Kulengowski B; Burgess DS
Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115117. PubMed ID: 32755805
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Zhang Y; Kashikar A; Bush K
J Antimicrob Chemother; 2017 Oct; 72(10):2792-2795. PubMed ID: 29091224
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions.
Castanheira M; Davis AP; Serio AW; Krause KM; Mendes RE
Diagn Microbiol Infect Dis; 2019 May; 94(1):73-77. PubMed ID: 30661726
[TBL] [Abstract][Full Text] [Related]
7. Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance.
Galani I; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Souli M;
BMC Infect Dis; 2019 Feb; 19(1):167. PubMed ID: 30770727
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of plazomicin and older aminoglyosides against Enterobacterales isolates; prevalence of aminoglycoside modifying enzymes and 16S rRNA methyltransferases.
Gür D; Hasdemir U; Çakar A; Çavuşoğlu İ; Çelik T; Aksu B;
Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115092. PubMed ID: 32569921
[TBL] [Abstract][Full Text] [Related]
9. Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates.
Denervaud-Tendon V; Poirel L; Connolly LE; Krause KM; Nordmann P
J Antimicrob Chemother; 2017 Oct; 72(10):2787-2791. PubMed ID: 29091226
[TBL] [Abstract][Full Text] [Related]
10.
Fleischmann WA; Greenwood-Quaintance KE; Patel R
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712206
[TBL] [Abstract][Full Text] [Related]
11. Distribution of genes encoding 16S rRNA methyltransferase in plazomicin-nonsusceptible carbapenemase-producing Enterobacterales in Brazil.
Bail L; Ito CAS; Arend LNVS; Pilonetto M; Nogueira KDS; Tuon FF
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115239. PubMed ID: 33130509
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers.
Martins AF; Bail L; Ito CAS; da Silva Nogueira K; Dalmolin TV; Martins AS; Rocha JLL; Serio AW; Tuon FF
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):228-232. PubMed ID: 29223516
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro activities of plazomicin and other aminoglycosides against clinical isolates of Klebsiella pneumoniae and Escherichia coli.
İnce G; Mirza HC; Üsküdar Güçlü A; Gümüş H; Erol Ç; Başustaoğlu A
J Antimicrob Chemother; 2021 Nov; 76(12):3192-3196. PubMed ID: 34499728
[TBL] [Abstract][Full Text] [Related]
14. ARGONAUT II Study of the
Jacobs MR; Good CE; Hujer AM; Abdelhamed AM; Rhoads DD; Hujer KM; Rudin SD; Domitrovic TN; Connolly LE; Krause KM; Patel R; Arias CA; Kreiswirth BN; Rojas LJ; D'Souza R; White RC; Brinkac LM; Nguyen K; Singh I; Fouts DE; van Duin D; Bonomo RA;
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152078
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Activity of Plazomicin Against Carbapenem Resistant Klebsiella pneumoniae Strains.
Demirbas Z; Ozger HS; Suzuk-Yildiz S; Bakkaloglu Z; Dizbay M
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704736
[TBL] [Abstract][Full Text] [Related]
16. Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers.
Sader HS; Mendes RE; Kimbrough JH; Kantro V; Castanheira M
Open Forum Infect Dis; 2023 Feb; 10(2):ofad058. PubMed ID: 36861086
[TBL] [Abstract][Full Text] [Related]
17. Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae.
Thwaites M; Hall D; Stoneburner A; Shinabarger D; Serio AW; Krause KM; Marra A; Pillar C
Diagn Microbiol Infect Dis; 2018 Dec; 92(4):338-345. PubMed ID: 30097297
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of plazomicin against quinolone-resistant gram-negative bacteria isolated from catheter-associated urinary tract infections.
Abd-Elmonsef MME; Nagla S; Afandy ME; Maxwell SY
J Chemother; 2021 Nov; 33(7):462-468. PubMed ID: 33810779
[TBL] [Abstract][Full Text] [Related]
20. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.
Livermore DM; Mushtaq S; Warner M; Zhang JC; Maharjan S; Doumith M; Woodford N
J Antimicrob Chemother; 2011 Jan; 66(1):48-53. PubMed ID: 21078604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
